{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:52:29Z","timestamp":1792749149702,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00270-022-03250-8","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T16:03:02Z","timestamp":1661529782000},"page":"1485-1493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiation Segmentectomy for the Treatment of Primary Hepatic Malignancies of the Caudate Lobe: A Case Series"],"prefix":"10.1007","volume":"45","author":[{"given":"Manasi","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau B.","family":"Toskich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Padula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Paz-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8143-6831","authenticated-orcid":false,"given":"Zlatko","family":"Devcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"3250_CR1","first-page":"20","volume":"45","author":"T Takayama","year":"1998","unstructured":"Takayama T, Makuuchi M. Segmental liver resections, present and future-caudate lobe resection for liver tumors. Hepatogastroenterology. 1998;45:20\u20133.","journal-title":"Hepatogastroenterology"},{"key":"3250_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/1097-0142(19861001)58:7<1557::AID-CNCR2820580729>3.0.CO;2-E","volume":"58","author":"K Takayasu","year":"1986","unstructured":"Takayasu K, Muramatsu Y, Shima Y, et al. Clinical and radiologic features of hepatocellular carcinoma originating in the caudate lobe. Cancer. 1986;58:1557\u201362.","journal-title":"Cancer"},{"key":"3250_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jamcollsurg.2004.10.036","volume":"200","author":"WG Hawkins","year":"2005","unstructured":"Hawkins WG, DeMatteo RP, Cohen MS, et al. Caudate hepatectomy for cancer: a single institution experience with 150 patients. J Am Coll Surg. 2005;200:345\u201352.","journal-title":"J Am Coll Surg"},{"key":"3250_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7819-11-220","volume":"11","author":"P Philips","year":"2013","unstructured":"Philips P, Farmer RW, Scoggins CR, et al. Caudate lobe resections: a single-center experience and evaluation of factors predictive of outcomes. World J Surg Oncol. 2013;11:1\u20136.","journal-title":"World J Surg Oncol"},{"key":"3250_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jamcollsurg.2006.09.020","volume":"204","author":"E Chaib","year":"2007","unstructured":"Chaib E, Ribeiro MAF Jr, eSilva FdSC, et al. Surgical approach for hepatic caudate lobectomy: review of 401 cases. J Am Coll Surg. 2007;204:118\u201327.","journal-title":"J Am Coll Surg"},{"key":"3250_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3748\/wjg.v16.i9.1123","volume":"16","author":"P Liu","year":"2010","unstructured":"Liu P, Yang J-M, Niu W-Y, et al. Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma. World J Gastroenterol WJG. 2010;16:1123.","journal-title":"World J Gastroenterol WJG"},{"key":"3250_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.amjsurg.2004.12.005","volume":"190","author":"S Tanaka","year":"2005","unstructured":"Tanaka S, Shimada M, Shirabe K, et al. Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe. Am J Surg. 2005;190:451\u20135.","journal-title":"Am J Surg"},{"key":"3250_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1148\/radiol.2016160718","volume":"283","author":"DM Biederman","year":"2017","unstructured":"Biederman DM, Titano JJ, Bishay VL, et al. Radiation segmentectomy versus TACE combined with microwave ablation for unresectable solitary hepatocellular carcinoma up to 3 cm: a propensity score matching study. Radiology. 2017;283:895\u2013905.","journal-title":"Radiology"},{"key":"3250_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s00270-011-0292-x","volume":"35","author":"SM Ibrahim","year":"2012","unstructured":"Ibrahim SM, Kulik L, Baker T, et al. Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization. Cardiovasc Intervent Radiol. 2012;35:1094\u2013101.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3250_CR10","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1148\/radiol.2018171768","volume":"287","author":"RJ Lewandowski","year":"2018","unstructured":"Lewandowski RJ, Gabr A, Abouchaleh N, et al. Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma. Radiology. 2018;287:1050\u20138.","journal-title":"Radiology"},{"key":"3250_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00270-016-1321-6","volume":"39","author":"MN Braat","year":"2016","unstructured":"Braat MN, van den Hoven AF, van Doormaal PJ, et al. The caudate lobe: the blind spot in radioembolization or an overlooked opportunity? Cardiovasc Intervent Radiol. 2016;39:847\u201354.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3250_CR12","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.jvir.2020.07.024","volume":"31","author":"H-C Kim","year":"2020","unstructured":"Kim H-C, Joo I, Lee M, et al. Benign biliary stricture after yttrium-90 radioembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2020;31:2014\u201321.","journal-title":"J Vasc Interv Radiol"},{"key":"3250_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jvir.2018.07.002","volume":"30","author":"H-C Kim","year":"2019","unstructured":"Kim H-C, Kim YJ, Lee J-H, et al. Feasibility of boosted radioembolization for hepatocellular carcinoma larger than 5 cm. J Vasc Interv Radiol. 2019;30:1\u20138.","journal-title":"J Vasc Interv Radiol"},{"key":"3250_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00004836-200105000-00013","volume":"32","author":"HK Kim","year":"2001","unstructured":"Kim HK, Chung Y-H, Song B-C, et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol. 2001;32:423\u20137.","journal-title":"J Clin Gastroenterol"},{"key":"3250_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00270-009-9781-6","volume":"33","author":"S Miyayama","year":"2010","unstructured":"Miyayama S, Yamashiro M, Okuda M, et al. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2010;33:1168\u201379.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3250_CR16","first-page":"2342","volume":"74","author":"R Salem","year":"2021","unstructured":"Salem R, Johnson GE, Kim E, et al. Yttrium-90 radioembolization for the treatment of solitary. Unresectable HCC LEGACY Study Hepatol. 2021;74:2342\u201352.","journal-title":"Unresectable HCC LEGACY Study Hepatol"},{"issue":"518\u2013526","key":"3250_CR17","volume":"32","author":"B Toskich","year":"2021","unstructured":"Toskich B, Vidal LL, Olson MT, et al. Pathologic response of hepatocellular carcinoma treated with yttrium-90 glass microsphere radiation segmentectomy prior to liver transplantation: a validation study. J Vasc Interv Radiol. 2021;32(518\u2013526): e511.","journal-title":"J Vasc Interv Radiol"},{"key":"3250_CR18","first-page":"211806","volume":"2022","author":"E Dhondt","year":"2022","unstructured":"Dhondt E, Lambert B, Hermie L, et al. 90Y radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled trial. Radiology. 2022;2022:211806.","journal-title":"Radiology"},{"key":"3250_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.tvir.2019.02.011","volume":"22","author":"BB Toskich","year":"2019","unstructured":"Toskich BB, Liu DM. Y90 radioembolization dosimetry: concepts for the interventional radiologist. Tech Vasc Interv Radiol. 2019;22:100\u201311.","journal-title":"Tech Vasc Interv Radiol"},{"key":"3250_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","volume":"72","author":"JM Llovet","year":"2020","unstructured":"Llovet JM, Lencioni R. mRECIST for HCC: performance and novel refinements. J Hepatol. 2020;72:288\u2013306.","journal-title":"J Hepatol"},{"key":"3250_CR21","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. November 2017:https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf. Accessed on: 20 Oct, 2021"},{"issue":"777\u2013785","key":"3250_CR22","volume":"28","author":"SA Padia","year":"2017","unstructured":"Padia SA, Johnson GE, Horton KJ, et al. Segmental Yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score\u2013matched study. J Vasc Interv Radiol. 2017;28(777\u2013785): e771.","journal-title":"J Vasc Interv Radiol"},{"key":"3250_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/hep.27057","volume":"60","author":"M Vouche","year":"2014","unstructured":"Vouche M, Habib A, Ward TJ, et al. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology. 2014;60:192\u2013201.","journal-title":"Hepatology"},{"key":"3250_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1447-073x.2004.00077.x","volume":"79","author":"U Lee","year":"2004","unstructured":"Lee U, Murakami G, Han S. Arterial supply and biliary drainage of the dorsal liver: a dissection study using controlled specimens. Anat Sci Int. 2004;79:158\u201366.","journal-title":"Anat Sci Int"},{"key":"3250_CR25","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jvir.2008.07.008","volume":"19","author":"CJ Yoon","year":"2008","unstructured":"Yoon CJ, Chung JW, Cho BH, et al. Hepatocellular carcinoma in the caudate lobe of the liver: angiographic analysis of tumor-feeding arteries according to subsegmental location. J Vasc Interv Radiol. 2008;19:1543\u201350.","journal-title":"J Vasc Interv Radiol"},{"key":"3250_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE, et al. Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:541\u201365.","journal-title":"J Natl Compr Canc Netw"},{"key":"3250_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76:681\u201393.","journal-title":"J Hepatol"},{"key":"3250_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.hpb.2019.09.008","volume":"22","author":"P Schullian","year":"2020","unstructured":"Schullian P, Laimer G, Putzer D, et al. Stereotactic radiofrequency ablation of primary liver tumors in the caudate lobe. HPB (Oxford). 2020;22:470\u20138.","journal-title":"HPB (Oxford)"},{"key":"3250_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4103\/jcrt.JCRT_341_19","volume":"16","author":"Y Yan","year":"2020","unstructured":"Yan Y, Lin ZY, Chen J. Analysis of imaging-guided thermal ablation puncture routes for tumors of the hepatic caudate lobe. J Cancer Res Ther. 2020;16:258\u201362.","journal-title":"J Cancer Res Ther"},{"key":"3250_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1148\/radiol.10100105","volume":"257","author":"H-C Kim","year":"2010","unstructured":"Kim H-C, Chung JW, Jae HJ, et al. Caudate lobe hepatocellular carcinoma treated with selective chemoembolization. Radiology. 2010;257:278\u201387.","journal-title":"Radiology"},{"key":"3250_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1051-0443(98)70307-0","volume":"9","author":"N Terayama","year":"1998","unstructured":"Terayama N, Miyayama S, Tatsu H, et al. Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe. J Vasc Interv Radiol. 1998;9:501\u20138.","journal-title":"J Vasc Interv Radiol"},{"key":"3250_CR32","doi-asserted-by":"crossref","unstructured":"Montazeri SA, De la Garza-Ramos C, Lewis AR, et al. Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors. Eur J Nucl Med Mol Imaging. 2022. Online ahead of print.","DOI":"10.1007\/s00259-022-05776-y"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03250-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T17:13:37Z","timestamp":1664990017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03250-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["3250"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03250-8","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author BT is an advisor to Boston Scientific Corporation, Sirtex, Johnson and Johnson, AstraZeneca, Genentech, Eisai, Histosonics, and Vivos. Authors MA, AL, CP, AM, CR, GF, RPF, MM, and ZD declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study has obtained IRB approval from Mayo Clinic College of Medicine and Science and the need for informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"For this type of study, consent for publication is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}